Navigation Links
Protein extremes gain relevance in massive proteomic studies
Date:6/15/2010

Researchers at University of Ghent, Belgium, and Universitat Autnoma de Barcelona (UAB) develop a new procedure to identify the two extremes of protein molecules and their processing and maturing in in-vivo and ex-vivo massive proteomic studies. The research has been published online at Nature Methods, under the title of "Complementary Positional Proteomics for Screening of Endo- and Exoproteases".

The world of proteins is one of the most complex and fundamental in living beings given that these biomolecules carry out and control or intervene in most biological functions. The massive identification and characterisation in a multitude of live organisms and in different vital stages has been and remains one of the most important tasks of proteomics, since it allows for further calibration of their role in biological functions and pathologies/diseases and to develop control strategies (e.g. drugs and vaccines).

Until recently most proteomic studies were focused on internal regions of proteins, usually those located in the three-dimensional folding (essential for many functions) or in the N-terminal (-Nt), with a free amine group (-NH2) at the start of the linear chain of linked amino acids. Protein molecules can have either few or hundreds (common in many organisms) and even thousands of linked amino acids, always in linear form, even if three-dimensional folding later takes place. This focalised research is due to the fact that procedures and chemistry needed to study N-terminal and internal regions are easier and can be developed quicker.

The new method developed by scientists helps to expand studies to C-terminal proteins (-Ct), proteins with a free carboxyl group, COOH, at the end of the linear chain of amino acids. The global and integrated strategy was created by research groups of the University of Ghent, Belgium (Petra van Damme, Kris Gevaert, et. al.) and UAB (Slvia Bronsoms and Francesc Xavier Aviles from the Institute of Biotechnology and Biomedicine and the Department of Biochemistry and Molecular Biology).

In other words, it is now possible to use massive proteomic methods to study maturing processes of proteins which often include breaks in their linear sequence both internally and at their N- and C-termini. Therefore, it will be possible to assess the specific role of these regions in the processes mentioned and in other related functions such as generation, activation and deactivation of hormones, growth factors, neuropeptides, enzymes, membrane receptors and many other proteins with important biological roles. The strategy developed can be carried out ex-vivo (in cell extracts) or in-vivo (by transfection and proteomic analysis). In addition, protein extremes are commonly involved in essential functions, such as locating and directing cells-tissues, triggering the start of three-dimensional folding, joining other biomolecules and macrostructures, post-generation chemical modifications of proteins, etc.

This publication completes previous studies (e.g. on N-terminal regions) carried out by the Flemish research group, leader in the field of general proteomics, as well as by researchers at Universitat Autnoma de Barcelona, leaders in the field of enzymes processing and maturing C-terminal proteins (carboxypeptidases), who recently published an article on the processing of C-terminal peptides in the Journal of Biological Chemistry, by S. Tanco, J. Lorenzo and F. X. Aviles, of UAB, and Ll. Fricker et. al. of Albert Einsten College of Medicine of New York.


'/>"/>

Contact: Maria Jesus Delgado
MariaJesus.Delgado@uab.cat
34-935-814-049
Universitat Autonoma de Barcelona
Source:Eurekalert  

Related biology news :

1. Protein could heal erectile dysfunction after cancer surgery
2. A balanced protein diet can reduce accumulation of nitrogen on dairy cattle farms by up to 35 percent
3. New function discovered in cancer prevention protein
4. Neural tissue contains imbalanced levels of proteins, U-M study finds
5. MIT chemists design new way to fluorescently label proteins
6. Bodys own proteins may lead the way in global fight against tuberculosis
7. Novel protein essential for successful pregnancy
8. Protein regulates enzyme linked to Alzheimers disease
9. Intracellular express -- why transport protein molecules have brakes
10. Protein power for Jack and the beanstalk
11. Study finds protein that plays key role in early embryonic development
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Protein extremes gain relevance in massive proteomic studies
(Date:2/2/2016)... 2016 Checkpoint Inhibitors for Cancer – ... Are you interested in the future of cancer ... inhibitors. Visiongain,s report gives those predictions to 2026 ... level. Avoid falling behind in data or ... revenues those emerging cancer therapies can achieve. There ...
(Date:2/1/2016)... -- Today, the first day of American Heart Month, the ... first of its kind workplace health solution that leverages ... first application of Watson to ... Welltok will create a new offering that combines AHA,s ... on Welltok,s health optimization platform. The effort is intended ...
(Date:1/25/2016)... 25, 2016  Glencoe Software, the world-leading supplier of ... industries, will provide the data management solution OMERO Plus ... Photo - ... Phenotypic analysis measures the characteristics and ... comparisons between states such as health and disease, the ...
Breaking Biology News(10 mins):
(Date:2/5/2016)... N.C. , Feb. 5, 2016  In the ... role for a host of launch activities including the ... of this launch activity is especially high in the ... Best Practices and the Role of Medical ... help companies focused on oncology therapies find better ways ...
(Date:2/4/2016)... - New FDA action date of July 22, ... July 22, 2016   --> - ...   - Lifitegrast has the potential to be the ... signs and symptoms of dry eye disease in adults ... product approved in the U.S. in the past decade indicated for the treatment of ...
(Date:2/4/2016)... 2016  CytoSorbents Corporation (NASDAQ: CTSO ), ... CytoSorb® blood filter to treat deadly inflammation in ... announced that CEO Dr. Phillip Chan , ... Group,s 2016 Disruptive Growth & Healthcare Conference, providing ... Conference Presentation Details: Where: Convene Conference ...
(Date:2/4/2016)... Sinovac Biotech Ltd. ("Sinovac" or the "Company") ... products in China , today announced ... received on February 4, 2016 a preliminary non-binding proposal ... of PKU V-Ming ( Shanghai ) Investment ... Development ( Shenzhen ) Fund Management Co., ...
Breaking Biology Technology: